Monthly Archives: February 2014

New collaboration with AtoZ-CRO

AtoZ-CRO GmbH from Germany and Abundnz B.V. will work in partnership for phase 0 micro dose studies. AtoZ-CRO is a full-service Clinical Research Organization with over 30 years of experience in Phase I – IV clinical studies.

Other partnerships with Abundnz.

Abundnz has partnerships with ImMunoSysLtd, IBIS Technologies, MsMetrix, Van Sonsbeek Software, InnoTherapy and Ducares.

Contact us for more information